PCSS-MOUD Exchange 4 – Session Roadmap, Session 4 – Implement/Sustain
Consider approaches to sustain MOUD and ensure continued access to high-quality care for our most challenged patients, including those who are pregnant, youth/adolescents, those with acute or chronic pain, and those electing to taper their dose.
PCSS-MOUD Exchange 4 – Session Roadmap, Session 3 – Implement/Sustain
Review considerations for MOUD initiation and follow-up, including lab guidelines, and clinical management of patients with continued use (e.g., fentanyl, novel synthetic opioids), overdose risk, poly-substance use, and comorbid mental health conditions.
PCSS-MOUD Exchange 4 – Session Roadmap, Session 2 – Prepare
Review patient screening considerations and discuss how OUD screening can be integrated into current clinic workflows. Discuss the training and certifications required for specific team members to implement MOUD. Highlight the critical role of Champions, and how to strategically select Champions to support MOUD implementation.
PCSS-MOUD Exchange 4 – Session Roadmap, Session 1 – Explore
Review medications for opioid use disorders (MOUD), with a focus on buprenorphine treatment and its various formulations. Discuss administrative, clinical and financial considerations, and provide resources for both prescribers and non-prescribers.
PCSS-MOUD Exchange 4 – Session Roadmap, Session 4 – Implement/Sustain
Consider approaches to sustain MOUD and ensure continued access to high-quality care for our most challenged patients, including those who are pregnant, youth/adolescents, those with acute or chronic pain, and those electing to taper their dose.
PCSS-MOUD Exchange 4 – Session Roadmap, Session 3 – Implement/Sustain
Review considerations for MOUD initiation and follow-up, including lab guidelines, and clinical management of patients with continued use (e.g., fentanyl, novel synthetic opioids), overdose risk, poly-substance use, and comorbid mental health conditions.
PCSS-MOUD Exchange 4 – Session Roadmap, Session 2 – Prepare
Review patient screening considerations and discuss how OUD screening can be integrated into current clinic workflows. Discuss the training and certifications required for specific team members to implement MOUD. Highlight the critical role of Champions, and how to strategically select Champions to support MOUD implementation.
PCSS-MOUD Exchange 4 – Session Roadmap, Session 1 – Explore
Review medications for opioid use disorders (MOUD), with a focus on buprenorphine treatment and its various formulations. Discuss administrative, clinical and financial considerations, and provide resources for both prescribers and non-prescribers.
PCSS-MOUD Exchange 4 – Session Roadmap, Session 4 – Implement/Sustain
Consider approaches to sustain MOUD and ensure continued access to high-quality care for our most challenged patients, including those who are pregnant, youth/adolescents, those with acute or chronic pain, and those electing to taper their dose.
PCSS-MOUD Exchange 4 – Session Roadmap, Session 3 – Implement/Sustain
Review considerations for MOUD initiation and follow-up, including lab guidelines, and clinical management of patients with continued use (e.g., fentanyl, novel synthetic opioids), overdose risk, poly-substance use, and comorbid mental health conditions.